Godman, B.; Shrank, W.; Wettermark, B.; Andersen, M.; Bishop, I.; Burkhardt, T.; Garuolienè, K.; Kalaba, M.; Laius, O.; Joppi, R.;
et al. Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe? Pharmaceuticals 2010, 3, 2470-2494.
https://doi.org/10.3390/ph3082470
AMA Style
Godman B, Shrank W, Wettermark B, Andersen M, Bishop I, Burkhardt T, Garuolienè K, Kalaba M, Laius O, Joppi R,
et al. Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe? Pharmaceuticals. 2010; 3(8):2470-2494.
https://doi.org/10.3390/ph3082470
Chicago/Turabian Style
Godman, Brian, William Shrank, Bjorn Wettermark, Morten Andersen, Iain Bishop, Thomas Burkhardt, Kristina Garuolienè, Marija Kalaba, Ott Laius, Roberta Joppi,
and et al. 2010. "Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?" Pharmaceuticals 3, no. 8: 2470-2494.
https://doi.org/10.3390/ph3082470
APA Style
Godman, B., Shrank, W., Wettermark, B., Andersen, M., Bishop, I., Burkhardt, T., Garuolienè, K., Kalaba, M., Laius, O., Joppi, R., Sermet, C., Schwabe, U., Teixeira, I., Tulunay, F. C., Wendykowska, K., Zara, C., & Gustafsson, L. L.
(2010). Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe? Pharmaceuticals, 3(8), 2470-2494.
https://doi.org/10.3390/ph3082470
